Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Calcium and cardiomyopathies.

E G Kranias1, D M Bers

  • 1Department of Pharmacology & Cell Biophysics, College of Medicine,University of Cincinnati, OH 45267-0575, USA. Litsa.kranias@uc.edu

Sub-Cellular Biochemistry
|January 16, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AB-1002 gene therapy expressing active protein phosphatase inhibitor-1 in heart failure: Rationale and study design of the GenePHIT trial.

European journal of heart failure·2026
Same author

Cardiotoxicity of environmental contaminant tributyltin involves myocyte oxidative stress and abnormal Ca<sup>2+</sup> handling.

Environmental pollution (Barking, Essex : 1987)·2019
Same author

Prevalence and cardiac phenotype of patients with a phospholamban mutation.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2018
Same author

Phospholamban ablation rescues the enhanced propensity to arrhythmias of mice with CaMKII-constitutive phosphorylation of RyR2 at site S2814.

The Journal of physiology·2015
Same author

A novel computational model of mouse myocyte electrophysiology to assess the synergy between Na+ loading and CaMKII.

The Journal of physiology·2014
Same author

Altered regional cardiac wall mechanics are associated with differential cardiomyocyte calcium handling due to nebulette mutations in preclinical inherited dilated cardiomyopathy.

Journal of molecular and cellular cardiology·2013
Same journal

Future Directions in Biotechnological and Pharmacological Applications of CAIs.

Sub-cellular biochemistry·2026
Same journal

Industrial and Environmental Applications of Carbonic Anhydrases.

Sub-cellular biochemistry·2026
Same journal

Applications of Carbonic Anhydrase Inhibitors in Arthritis, Neuropathic Pain, Acute Mountain Sickness, and Cerebral Ischemia.

Sub-cellular biochemistry·2026
Same journal

Applications of Carbonic Anhydrase Inhibitors in Neurological Disorders, Mechanisms and Therapeutic Potential.

Sub-cellular biochemistry·2026
Same journal

Carbonic Anhydrase Inhibitors in Oncology.

Sub-cellular biochemistry·2026
Same journal

Therapeutic Applications of Carbonic Anhydrase Inhibitors in Ophthalmology.

Sub-cellular biochemistry·2026
See all related articles

Sarcoplasmic reticulum (SR) proteins regulate cardiac calcium (Ca) cycling, essential for heart function. Genetic variants in these proteins are linked to heart failure and arrhythmias.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Cardiac excitation-contraction (E-C) coupling relies on sarcoplasmic reticulum (SR) calcium (Ca) cycling.
  • Dysfunctional Ca cycling in the SR network characterizes cardiac hypertrophy and heart failure.
  • Key SR Ca-handling proteins include SERCA, phospholamban (PLN), calsequestrin, and the ryanodine receptor (RyR).

Purpose of the Study:

  • To review the critical role of SR Ca-cycling proteins in cardiac health and disease.
  • To highlight recent findings on genetic modifiers of SR Ca-cycling proteins.

Main Methods:

  • Review of existing literature on SR Ca-cycling proteins.
  • Focus on genetic variants and their impact on cardiomyopathies.
  • Analysis of protein function in cardiac relaxation, Ca-load, and Ca-release.

Related Experiment Videos

Main Results:

  • Altered levels or activity of SERCA, PLN, calsequestrin, and RyR are observed in cardiomyopathies.
  • These alterations correlate with impaired cardiac function and remodeling.
  • Genetic variations in SR Ca-cycling proteins can predispose individuals to heart failure and arrhythmias.

Conclusions:

  • SR Ca-cycling proteins are pivotal in maintaining cardiac function.
  • Dysregulation and genetic variants of these proteins are implicated in heart disease pathogenesis.
  • Understanding these proteins and their genetic modifiers is crucial for diagnosing and treating cardiomyopathies.